Healthcare -
Biotechnology - NASDAQ - US
$ 3.345
1.36 %
$ 634 M
Market Cap
-7.78
P/E
ABUS - SHORT-TERM INVESTMENTS
Short-term Investments ABUS - Arbutus Biopharma Corporation
99.7 M
LAST VALUE
47.18%
2 YEAR CAGR
2.60%
5 YEAR CAGR
0.00%
10 YEAR CAGR